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The detrimental effects of oxidative stress on the skeletal system have been documented, and under-
standing the mechanisms is important to design a therapeutic strategy. As an antioxidant and anti-
inﬂammatory agent, the active ingredient of turmeric curcumin has been used as medication for
numerous complications including bone loss. However, it is unclear if curcumin could inﬂuence the
osteogenic potential of mesenchymal stem cells (MSCs), particularly in oxidative injuries. Here we
demonstrate that curcumin treatment protects cell death caused by hydrogen peroxide (H2O2) exposure
in human adipose-derived MSCs in vitro. Importantly, curcumin is able to enhance the osteoblast dif-
ferentiation of human adipose-derived MSCs that is inhibited by H2O2. Notably, both oxidative stress and
the inhibition of Wnt/b-catenin signaling are attenuated by curcumin treatment. These results suggest
that curcumin can promote osteoblast differentiation of MSCs and protect the inhibitory effect elicited by
oxidative injury. The ﬁndings support potential use of curcumin or related antioxidants in MSC-based
bone regeneration for disease related with oxidative stress-induced bone loss.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Mesenchymal stem cell (MSC) is one of the major candidates to
treat human degenerative diseases (1e3). With potential to
differentiate into all bone cell types, MSCs may improve healing of
bone defects and even reverse clinically signiﬁcant abnormalities in
the skeleton system (4e6). In order to regenerate the complex
collagen structure with appropriate mechanical properties, MSC-
based approaches need to be capable of facilitating beneﬁcial
bone remodeling and mitigating bone injury. It has been reported
that MSC can induce the repair process in fracture by replenishing
bone cells including chondrocytes and osteoblasts. The increasedSurgery, The First Afﬁliated
of Jianshe Road, Zhengzhou
rmacological Society.
nd should be considered as
g by Elsevier B.V. on behalf of Japa
d/4.0/).numbers or activity of bone marrowMSCs have also been proposed
to act effectively with parathyroid hormone (PTH) for treating
osteoporosis (7). Furthermore, anti-inﬂammatory paracrine func-
tions of MSCs have been suggested in several animal models of
inﬂammation-associated diseases (8), which might play critical
roles in modulating the inﬂammatory environment for optimal
bone repair. The recent development of technique has greatly
improved the in vitro isolation and expansion of adult mesen-
chymal stem cells (9e11). However, challenges remain for effective
treatment. How to maintain the survival, growth, and osteogenic
potential of transplanted MSCs are particularly limiting factors. As
critical mediators of pathophysiological responses, reactive oxygen
species (ROS) and free radicals have been implicated as negative
regulators for bone homeostasis. For instance, the activation of
bone resorption by oxidative stress has been extensively studied
(12e14). In patients with inﬂammatory bone diseases, oxidative
stress often downregulates bone formation by decreasing osteo-
blast number and differentiation (13). These detrimental effects can
also be extended to MSCs, including the induction of apoptosis and
delay of osteogenesis (15,16). Based on these considerations, annese Pharmacological Society. This is an open access article under the CC BY-NC-ND
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venting ROS damage on osteogenic progenitors.
Curcumin (1, 7-bis (4-hydroxy-3-methoxyphenyl)-1, 6-
heptadiene-3,5-dione), a phenolic antioxidant derived from In-
dian herbal medicine turmeric, is a potent free radical scavenger.
The cytoprotection roles of curcumin have been demonstrated in
alleviating tissue damages elicited from lipid peroxidation, nitric
oxide (NO)-based free radicals, and hypoxia. In general, the pleio-
tropic activities of curcumin include the antitumor property and
the mainly protective functions to oxidative injuries during
inﬂammation or aging related scenarios (17). A low dose of dietary
curcumin signiﬁcantly decreased inﬂammation and b-amyloid
plaque in the brains of a mouse model of Alzheimer's disease (18).
Curcuminwas shown to protect the hepatic injury and liver ﬁbrosis
(19). It was also reported that curcumin administration prevented
diabetes-induced retina inﬂammation (20). In addition, curcumin
treatment can prevent hippocampal neurons from traumatic injury
such as cerebral ischemia (21). Recent ﬁndings suggest the possi-
bility that curcumin may inﬂuence progenitor/stem cell. Besides
extensively reported inhibitory effects on cancer stem cell pop-
ulations, curcumin can induce embryonic stem cell differentiation
through NO-cyclic guanosine monophosphate (GMP) pathway
(22,23). A stimulating effect on neurogenesis by curcumin has also
been found (24). The effects of curcumin in bone metabolism have
been investigated as well. Some studies have suggested that cur-
cumin can reduce osteoclast activation (25). On the other hand, the
actions of curcumin on osteoblast cells are mixed (26,27), and it has
been suggested curcumin can promote osteoblast differentiation of
MSCs in vitro (26). Nevertheless, it is still unclear whether the
suppression of bone formation during oxidative cell damages could
be reversed by curcumin and which signaling pathway may be
related to the function of curcumin in MSCs.
We hypothesized that curcumin can protect MSCs from
oxidative stress-induced injury. In human adipose-derived MSCs
(aMSCs), we found curcumin was able to prevent the cell death,
ameliorate oxidative stress, and reverse the inhibition on osteo-
genic differentiation induced by H2O2 treatment in vitro. Inter-
estingly, a critical signaling in bone formation pathway, Wnt/b-
catenin-regulated cyclin D1 is reduced in H2O2-challenged aMSCs,
which can be prevented by curcumin. An inhibitor of Wnt
pathway blocked such protection by curcumin. These data sug-
gested a novel mechanism involved in the protective roles of
curcumin against oxidative injuries in mesenchymal stem cells
under osteoblast differentiation.
2. Materials & methods
2.1. Human adipose-derived mesenchymal stem cell culture
Human adipose tissues that were collected by needle biopsy or
liposuction aspiration in the First Afﬁliated Hospital of Zhengzhou
University. Tissue samples were ﬁrst extensively washed with
phosphate-buffered saline (PBS) containing penicillin/strepto-
mycin followed by digestion using 0.075% collagenase Type I for
30 min at 37 C. The stromal vascular fractions (SVF), containing
the MSCs (28), were obtained by centrifugation at 2000 rpm for
5 min. After the separation of the stromal cells from the primary
adipocytes, the pellets were resuspended in 1 ml lysis buffer and
incubated for 10 min on ice. The cell pellet was resuspended in
stromal medium (alpha-MEM, supplemented with 20% fetal
bovine serum (FBS), 1% L-glutamine, and 1% penicillin/strepto-
mycin) and ﬁltered through 70 mm cell strainer. Cells were plated
and washed three days later with fresh stromal medium. The cells
were maintained in a humidiﬁed tissue culture incubator at 37 C
with 5% CO2, and media was changed every second day until thecells reach 80% conﬂuence. This study was approved by The Local
Ethical Review Board of the First Afﬁliated Hospital of Zhengzhou
University and written informed consent was obtained from all
patients.
2.2. Induction of osteoblast differentiation of human aMSCs
Human aMSCs were induced with osteogenic differentiation
medium: Ham's F12 Coon's modiﬁcation medium supplemented
with 10% FBS (Gibco, Grand Island, NY), 100 IU/ml penicillin,
100 mg/ml streptomycin, 10 nM dexamethasone, 0.2 mM sodium
L-ascorbyl-2-phosphate, and 10 mM b-glycerol phosphate. Dif-
ferentiation medium was changed every third day. Vehicle con-
trols and H2O2 (0.1, 0.2, 0.5, 1 or 2 mM) were added in aMSCs for
the ﬁrst 24 h of culturing, and curcumin (1, 5, 10, 20, 50 or
100 mM) was added in the differentiation media throughout the
differentiation processes until harvest for assays. The alkaline
phosphatase (ALP) activity was determined at day 8, and Alizarin
red-sulfate (ARS) staining was performed at day 16 of the
differentiation.
2.3. Flow cytometry
The surface markers for human aMSCs were conﬁrmed by ﬂow
cytometry. Undifferentiated MSCs were trypsinized and counted.
The same number of cells was resuspended in FACS buffer (PBS
containing 2% FBS), and aliquots were stained by FITC or PE-
conjugated antibodies for human CD34, CD45, CD29, CD44, or
CD105, respectively (eBioscience, San Diego, CA). Negative-stained
cells were used to optimize the settings of analyzing in BD-FACScan
(Franklin Lakes, NJ), and data were analyzed with FlowJo.
2.4. RT-PCR
We used RNeasy kit (Qiagen, Valencia, CA) or Trizol (Invitrogen,
Pleasanton, CA) to isolate total RNA from cells at the indicated time
points. The RNAs were reverse transcribed to complementary
cDNAs using Superscript III (Invitrogen) according to manufac-
turer's instructions. A SYBR Green dye-based detectionmethod was
used by master mixes for quantitative real-time PCR (Applied Bio-
systems, Waltham, MA). The PCR reactions were performed in
triplicated samples, and serial dilutions of control cDNA were used
to make a standard curve for each gene expression. The speciﬁc
primers were used including: OPN, forward: 50-TTGCAGCCTTCT-
CAGCCAA-30, reverse: 50-GGAGGCAAAAGCAAATCACTG-30; Collagen
I, forward: 50-GAGGGCCAAGACGAAGACATC-30, reverse: 50-CAGAT-
CACGTCATCGCACAAC-30; OPG, forward: 50-GTGTGCGAATGCAAG-
GAAGG-30, reverse: 50-CCACTCCAAATCCAGGAGGG-30; RANKL,
forward: 50-CAACATATCGTTGGATCACAGCA-30, reverse: 50-GACA-
GACTCACTTTATGGGAACC-30; b-catenin, forward: 50-AGCTTCCA-
GACACGCTATCAT-30, reverse: 50- CGGTACAACGAGCTGTTTCTAC-30;
Cyclin D1, forward: 50-GCTGCGAAGTGGAAACCATC-30, reverse: 50-
CCTCCTTCTGCACACATTTGAA-30 and GAPDH, forward: 50-
CTGGGCTACACTGAGCACC-30, reverse: 50-AAGTGGTCGTTGAGGG-
CAATG-30. The results were normalized by the expression of
GAPDH.
2.5. Western blotting
Cells were lysed (10 mM HEPES, pH 7.4, 1.5 mM MgCl2, 10 mM
KCl, 1% NP40, with protease inhibitors) followed by centrifugation
at 12,000 rpm for 10 min at 4 C. The supernatants were collected
and protein concentrations were determined by BCA protein as-
says. The same amounts of proteins were subjected to SDS-PAGE,
followed by electric transfer into PVDF membrane. The
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bodies of b-catenin, Cyclin D1, GAPDH (Cell signaling, Danvers, MA),
GSK-3b, p-GSK-3b (tyrosine 216) and C-myc (Abcam, Cambridge,
MA). The images were then analyzed by ImageJ and the levels were
normalized by GAPDH.
2.6. Osteogenic differentiation assays
ALP activity assay was performed in adherent cell culture after
osteogenic differentiation in the various conditions as indicated.
The levels of ALP activity were measured by a colorimetric assay
based on enzymatic reactions that used freshly prepared colori-
metric substrate para-nitrophenyl phosphate. The enzymatic
reaction was carried out at 37 C for 30 min, and stopped by
adding NaOH (0.2 M). The optical density of the product para-
nitrophenol was determined at a wavelength of 405 nm. The
ALP activity was normalized by protein content and expressed as
relative fold.
For monitoring mineralization of the differentiated osteoblasts,
cells were also stained for ALP activity or Alizarin red in culture
dish. For ALP staining, cells were ﬁxed with 4% paraformaldehyde
(PFA) for 30 min at room temperature, then rinsed twice with PBS
followed by staining in freshly prepared 0.1% naphthol AS-MX
phosphate, 56 mM 2-amino-2-methyl-1-3-propanediol, and 0.1%
fast red violet LB salt. For ARS staining (29) to evaluate the
mineralization nodules formed, MSCs after osteogenic induction
were treated by 40 mM AR-S (pH 4.2) with gentle rocking for
30 min on room temperature. The stained cells were examined and
imaged by light microscopy.
2.7. Calcium accumulation assay
Calcium accumulation in mineralized cells in differentiation
conditions was also determined by a calcium Assay kit (Genzyme
Diagnostics, Charlottetown, PE, Canada). Brieﬂy, the samples were
mixed with acetic acid (1 M) and then incubated at 4 C overnight
for the extraction of the calcium from the mineralized matrix. Then
the absorbance at 650 nm was measured. The samples were
measured in triplicate and compared to the calcium calibration
curve. The calcium content was normalized by cell numbers and
expressed as relative fold change.
2.8. The assessment of oxidative stress
The oxidative stress induced by the exposure of H2O2 was
assessed by the measurements of the levels of glutathione (GSH),
superoxide dismutase (SOD), and malondialdehyde (MDA). The
cell homogenates were spin and aliquots taken from the super-
natant were used in the assays. GSH content was measured by
mixing with DTNB (5, 5-dithiobes-(2-nitrobenzoic acid)) at
pH ¼ 7.4 followed by spectrometry at 412 nm. A SOD assay kit
(Cayman chemical, Ann Arbor, MI) was used for the amount of
enzyme needed for dismutation of the superoxide radical. The
levels of MDA were determined by heating with thiobarbituric
acid at 95 C followed by spectrometry at 532 nm. The numbers
were calculated and normalized with protein concentrations. The
data are expressed as the relative levels to vehicle controls.
2.9. Statistics
All data in graphs are expressed as the means ± SD as indicated.
One-way ANOVA analysis followed by a Tukey's post hoc test was
performed, and the signiﬁcances of the comparisons were indi-
cated when p < 0.05.3. Results
3.1. Curcumin protects human aMSCs from H2O2-induced cell death
To investigate curcumin effects on MSCs, we ﬁrst obtained MSCs
derived from human adipose tissue (stromal vascular fractions (28),
seen in Fig. 1a). The cell identity as bona ﬁde human stromal pro-
genitor cells was conﬁrmed by the analysis of well-accepted surface
markers. Flow cytometry demonstrated these cells are positive for
CD29, CD44, CD105, and negative for CD34 and CD45 (Fig. 1bef). It
has been reported that cell death can be induced by oxidative
stimuli such as H2O2. We then examined the effects of H2O2 on
aMSCs cell viability in the absence or presence of the co-treatment
of curcumin. We tested a series of concentrations of H2O2 (0.1, 0.2,
0.5, 1, and 2 mM, treated for the ﬁrst 24 h of the culturing) as
suggested in prior reports. As shown in Fig. 1g, increasing con-
centrations of H2O2 signiﬁcantly reduced cell viability of aMSCs.
The similar approach was also used to test the toxicity of curcumin.
Only high doses (50 and 100 mM) of curcumin increased the cell
death (Fig. 1h). Moreover, if curcuminwas added in cells exposed to
0.2 mMH2O2, increased doses of curcumin (20 mM) could prevent
the H2O2-induced cell death in aMSCs in a dose-dependent manner
(Fig. 1i). On the other hand, high doses of curcumin (at 50 or
100 mM) combined with H2O2 decreased cell viability. These data
suggest that curcumin at appropriate concentrations appears to
reverse H2O2-induced cell death of aMSCs.
3.2. Curcumin protects the H2O2-induced inhibition of osteogenesis
of human aMSCs
In order to elucidate the effects of H2O2 and curcumin on oste-
ogenic differentiation of human aMSCs, we induced the osteoblast
differentiation in aMSCs in the presence of H2O2 or curcumin. Both
conditions showed similar results as the previous ﬁndings on cell
viability. H2O2 exposure dramatically decreased ALP activity and
calcium content in differentiated aMSCs (Fig. 2a and b). These ef-
fects were seen when H2O2 reaches to 0.2 mM. In contrast, the
osteogenic differentiation was promoted by curcumin at low doses
(5e20 mM) but was inhibited by high doses of curcumin (at 50 and
100 mM, Fig. 2a and b). Notably, in the presence of 20 mM curcumin,
H2O2 (at 0.2 mM concentration) could not longer to inhibit the
osteoblast differentiation of aMSCs, as shown by the ALP and ARS
staining (Fig. 2c), recovered ALP activity (Fig. 2d), and enhanced
calcium contents (Fig. 2e). Furthermore, we also examined the gene
markers of bone regulation during the co-treatments (Fig. 3). The
osteogenesis markers OPN (osteopontin) and Collagen 1 (collagen
type I) decreased in response to 0.2 mM H2O2 and was upregulated
by 20 mM curcumin that also reversed the reduction of gene ex-
pressions by H2O2 (Fig. 3a). The bone remodeling markers OPG
(osteoprotegrin) and RANKL (receptor activator of nuclear factor
kappa-B ligand) were also measured (Fig. 3b). While the expression
of OPG was unaffected in all conditions, RANKL expression in
differentiated aMSCs was enhanced by H2O2 treatment that was
blocked by the treatment of 20 mM curcumin.
3.3. Curcumin ameliorates H2O2-induced oxidative stress in human
aMSCs
Since curcumin has antioxidant effects, we carried out a series of
experiments to assess oxidative stress in aMSCs treated by H2O2 in
the absence or presence of curcumin (Fig. 4). As expected, cells
exposed to 0.2 mM H2O2 had enhanced oxidative stress, demon-
strated by the decreased GSH level, reduced SOD activity, and
increased MDA level. In contrast, curcumin had the exact opposite
effects in aMSCs as H2O2 (Fig. 4aec). Importantly, the oxidative
Fig. 1. Curcumin treatment rescues cell death caused by H2O2 exposure in human aMSCs. (a) Representative image of human aMSCs. Scale bar, 100 mm. (bef) Human aMSCs were
characterized by ﬂow cytometry, indicating most of the cells were CD34, CD45, CD29þ, CD44þ and CD105þ. Effects of H2O2 (0.1, 0.2, 0.5, 1 and 2 mM) exposure for the ﬁrst 24 h
during culturing (g), curcumin (1, 5, 10, 20, 50 and 100 mM) without 0.2 mM H2O2 exposure (h) and with 0.2 mM H2O2 exposure (i) on human aMSC viability. Cell viability was
measured by MTT assay at day 5 after seeding. Data were given as mean ± SD. *p < 0.05 and **p < 0.01 compared to control.
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in the presence of curcumin, suggesting a critical involvement of
ROS in the osteogenesis inhibition in human aMSCs.3.4. Wnt pathway is involved in the protective effects of curcumin
in human aMSCs
We next investigated the potential signaling pathway that is
involved in the protective function of curcumin in osteogenic dif-
ferentiation of human aMSCs. As a key modulator of osteoblast
differentiation and bone homeostasis, we focused on Wnt/b-cat-
enin pathway (30). Consistent with previous ﬁndings (31), we
observed that H2O2 suppressed Wnt signaling, as shown by the
downregulated expressions of b-catenin and its target protein
cyclin D1 in human aMSCs, also the key protein in Wnt pathway, C-
myc (Fig. 5a). Another key proteins, p-GSK-3b (tyrosine 216) and
GSK-3b, were elevated by H2O2 treatment. Interestingly, 20 mM
curcumin increased only b-catenin expression and decreased ex-
pressions of p-GSK-3b and GSK-3b in the absence of H2O2, while all
the ﬁve proteins levels (b-catenin, p-GSK-3b, GSK-3b, C-myc and
cyclin D1) were rescued by curcumin in aMSCs treated with H2O2
(Fig. 5). These data suggested that the inhibition of Wnt/b-catenin
signaling might mediate the suppression of osteogenesis of human
mesenchymal stem cells by H2O2, a mechanism can be targeted bycurcumin. Furthermore, wnt3a (a Wnt pathway ligand, 100 ng/ml)
and DKK1 (Dickkopf, a Wnt pathway inhibitor, 0.2 mg/ml) were
used to conﬁrm the involvement of Wnt pathway in the protective
effects of curcumin. There was no statistic difference in the four
proteins expressions mentioned above between wnt3a group and
wnt3a þ curcumin group (Fig. 5b), indirectly suggesting curcumin
may exert its effect through Wnt pathway. Meanwhile, curcumin
treatment was somehowable to increase the decrease of C-myc and
cyclin D1 expressions by DKK1 treatment (Fig. 5b). To further test
this hypothesis, we investigated the osteogenic differentiation of
aMSCs usingwnt3a and DKK1with or without curcumin treatment.
As Fig. 5c shows, 20 mM curcumin prevented the inhibition of
osteogenesis by H2O2 in a Wnt-dependent manner, which can be
blocked by DKK1. Also, if co-treated with wnt3a, curcumin failed to
further promote osteogenesis in the presence of H2O2 compared to
H2O2þwnt3a group. Similar results were found in the calcium
accumulation (Fig. 5d).4. Discussion
In this study, we demonstrated that curcumin in human aMSCs
could play a protective function against oxidative insult such as
hydrogen peroxide exposure. Consistent with prior studies, our
data have shown that H2O2 can stimulate cell death, induce
Fig. 2. Curcumin protects the H2O2-induced inhibition of osteogenesis of human aMSCs. Effects of H2O2 exposure (0.1, 0.2, 0.5, 1 and 2 mM) and curcumin treatment (1, 5, 10, 20, 50
and 100 mM) on ALP activity (a) and calcium content (b) in aMSCs. (c) Representative images for alizarin red staining and alkaline phosphatase staining in control, 0.2 mM H2O2,
20 mM curcumin, the combination of 0.2 mM H2O2 and 20 mM curcumin groups. Relative ALP activity (d) and calcium content (e) in these four groups were shown. Data were given
as mean ± SD. *p < 0.05 and **p < 0.01 compared to control, ##p < 0.01 compared to 0.2 mM H2O2 group.
Fig. 3. Effects of curcumin (20 mM) on osteogenic differentiation of human aMSCs exposed to 0.2 mM H2O2, analyzed by relative OPN, Collagen I mRNA expression (a) and OPG and
RANKLmRNA expression (b). mRNA expressions were characterized by RT-PCR analysis and normalized to GAPDH. Data were given as mean ± SD. *p < 0.05 and **p < 0.01 compared
to control, ##p < 0.01 compared to 0.2 mM H2O2 group.
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Fig. 4. Curcumin (20 mM) ameliorates 0.2 mM H2O2-induced oxidative stress in human aMSCs, including GSH levels (a), SOD activity (b) and MDA levels (c). aMSCs were measured
at day 7 after seeding. Data were given as mean ± SD. **p < 0.01 compared to control, ##p < 0.01 compared to 0.2 mM H2O2 group.
N. Wang et al. / Journal of Pharmacological Sciences 132 (2016) 192e200 197oxidative stress, and impede osteoblast differentiation in human
aMSCs. A counter role was found for curcumin in aMSCs that
reversed the detrimental effects of H2O2 on the osteogenic differ-
entiation process, which might be mediated through a canonical
Wnt signaling pathway.
Based on these ﬁndings, we provide novel insight into the
development of stem cell-based therapies for inﬂammatory bone
diseases where oxidative stress plays an essential pathogenic role
(12e14). In particular, hydrogen peroxide represents an impor-
tant ROS signal for adverse changes in aging or traumatic tissue
injuries when reaches a high intracellular concentration. Mean-
while, the endogenous defense mechanisms are saturated so the
increase of ROS couldn't be neutralized anymore by antioxidant
enzyme SOD or detoxiﬁer GSH. As a result, H2O2 can cause the
opening of the permeability transition pore of mitochondrial,
leading to cell damages including apoptosis or other cell defects.
In agreement with the notions that oxidative stress is involved in
the decline of bone mass and strength during aging, strong evi-
dences have suggested that oxidative stress is a pivotal patho-
genic mechanism of the age-related bone diseases. For bone
resorption activity, oxidative stress enhances osteoclastogenesis.
H2O2 can induce osteoclast-mediated resorption and low bone
mass in postmenopausal women through upregulation of RANKL
and M-CSF expression (13). It was demonstrated that H2O2 is
involved in osteoclast-dependent bone loss of estrogen deﬁ-
ciency (32). On the other hand, hydrogen peroxide treatment was
known to cause the inhibition of bone formation phase as well,
such as decreasing differentiation markers in bone osteoblastic
cell lines (33). Consistent with these ﬁndings, we also found
H2O2 elicited a series of negative impacts on osteogenesis of
aMSCs. Furthermore, RANKL expression is increased in aMSCs
exposed to H2O2, suggesting an indirect effect of oxidative stress
in stimulating osteoclast-dependent bone resorption. It therefore
seems that both arms of bone remodeling can be affected by
oxidative stress, synergistically leading towards a reduction of
bone mass.
Supporting the ﬁndings of prior research, our experiments
indicated that antioxidant such as curcumin could be a promising
option for treating bone loss due to oxidative injuries. First, cell
death stimulated by H2O2 was prevented by curcumin treatment.
Similarly, curcumin could reverse the inhibition of osteogenic
differentiation by H2O2, manifested by the recovered ALP activity,
calcium accumulation, and osteoblastic marker gene expressions.
Second, the expression of bone remodeling genes was affected by
curcumin in aMSCs. H2O2 inhibits OPN and Col 1 whereas in-
creases RANKL expression, presumably inducing a vicious cycle to
suppress osteogenesis of aMSCs. This effect was rescued by cur-
cumin treatment, reinforcing its protective role in osteogenesisinhibition by oxidative injury. Accordingly, the H2O2-induced
oxidative stress was substantially attenuated by curcumin,
consistent with its property as an antioxidant agent (17). More-
over, the concentration of curcumin appears to be crucial for its
action on MSC cell survival and osteogenic differentiation (Figs. 1
and 2). Although the lower doses (such as 20 mM) of curcumin
played beneﬁcial roles, higher doses acted in the opposite di-
rections. Both 50 and 100 mMcurcuminwas shown to simulate cell
death and unable to withstand the oxidative injures induced by
H2O2 in osteogenic differentiation of aMSCs. In fact, it has been
previously observed that curcumin has a negative impact on
osteoblastic cells such as rat calvarial osteoblast-like cells (27). In
contrast, the osteogenic differentiation of bone marrow MSCs is
promoted by curcumin (26). Our data suggest that the discrepancy
of these ﬁndings might be contributed by the various types of cells
that respond differently to curcumin in a dose-dependent
manner. Thus, an in vivo approach (such as (34)) should be
taken to further clarify the effect of curcumin on osteogenesis and
MSC-based treatment efﬁciency in animal models of oxidative
injuries.
The precise molecular mechanisms by which curcumin pro-
vided protections against H2O2-induced osteogenesis inhibition
require further studies, and our present study has warranted a
continuous interest on Wnt/b-catenin signaling that is critically
involved in bone homeostasis. The canonical Wnt signaling is
mediated through b-Catenin that binds to and activate members
of the T cell factor (TCF)/lymphoid enhancer factor (LEF) tran-
scription factor family (30). The important role of Wnt/b-catenin
signaling in bone biology has been demonstrated by numerous
genetic evidence that loss- or gain-of-function mutations in the
pathway cause dramatic bone phenotypes (30). Moreover, a
neutralizing antibody for blocking sclerostin, the endogenously
secreted Wnt/b-catenin inhibitor, can dramatically enhance bone
formation and is currently under development as an anabolic
bone therapy for patients with low bone mass (35). Additionally,
Wnt/b-catenin signaling is critical in the commitment of multi-
potent mesenchymal progenitors to the osteoblastic lineage,
which is important for stem cell-based therapy and often
impaired in degenerative bone diseases. It has been speciﬁcally
suggested that Wnt pathway is implicated in oxidative damages
on both uncommitted osteoblast progenitors and differentiated
osteoblasts through b-catenin-dependent mechanisms. For
instance, b-catenin is implicated in the cellular defensive
response to oxidative stress by serving as a cofactor of the
forkhead box O (FoxO) transcription activation such as the
increased expression of Gadd45, Catalase, or Mn-SOD (31). Thus,
oxidative stress that diverts the limited pool of b-catenin from
TCF to FoxO would promote FoxO-dependent cellular defense at
Fig. 5. Role of Wnt pathway in the protective effects of curcumin on the 0.2 mM H2O2-induced inhibition of osteogenic differentiation of human aMSCs. Protein expressions of Wnt
pathway-related regulators b-catenin and cyclin D1, and key proteins p-GSK-3b (tyrosine 216), GSK-3b and C-myc in the four experimental groups (control, 0.2 mM H2O2, 20 mM
curcumin, the combination of 0.2 mM H2O2 and 20 mM curcumin groups) were analyzed by western blot (a). (b) b-Catenin, p-GSK-3b, GSK-3b, C-myc and cyclin D1 protein ex-
pressions in the presence of wnt3a (Wnt pathway ligand) and DKK-1 (Wnt pathway inhibitor) with or without curcumin treatment. ALP activity (c) and calcium contents (d) in the
following groups: control, H2O2 group, H2O2þwnt3a group, H2O2þwnt3a þ curcumin group, H2O2þ curcumin group, H2O2þ curcumin þ DKK1 group. Data were given as
mean ± SD. n.s indicates no statistical signiﬁcance. *p < 0.05 and **p < 0.01 compared to control, ##p < 0.01 compared to 0.2 mM H2O2 group, þþp < 0.01 compared to DKK1 group,
^^ p < 0.01 compared to H2O2þ curcumin group.
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antagonism between Wnt signaling and age-dependent increase
in oxidative stress therefore may contribute to the development
of osteoporosis. The present in vitro data agree with this hy-
pothesis by showing antioxidant curcumin can diminish the ef-
fects of H2O2 on aMSCs in which the Wnt-dependent
osteogenesis is inhibited by oxidative stress. The conclusion
was also substantiated by the observation that a blockade of Wnt
signaling by DKK1 treatment completely abolished the protection
by curcumin, and by the ﬁnding that wnt3a treatment was able
to mask the effects of curcumin. It was found that co-treatment
of wnt3a was able to mask the protective effects of curcumin,in terms of both the Wnt pathway-related proteins expressions
and the osteogenesis. Oppositely, co-treatment of DKK1 abol-
ished the effects of curcumin. These results further clearly indi-
cate the involvement of Wnt signaling pathway in the observed
effects of curcumin. Such Wnt-dependent effect is most likely
associated with the attenuated oxidative stress by curcumin
treatment, although a direct role on Wnt/b-catenin pathway is
possible. GSK-3b is a very important protein related in Wnt
signaling pathway. GSK-3b, as well as Axin and casein kinase 1a,
constitutes a b-catenin destruction complex, which recruits b-
catenin into this complex and phosphorylates b-catenin, leading
to subsequent ubiquitination and degradation (36). This results
N. Wang et al. / Journal of Pharmacological Sciences 132 (2016) 192e200 199in low levels of b-catenin in the cytoplasm, leading to repression
of Wnt signaling pathway (36). It is known that curcumin is able
to reduce the components of the destruction complex that tar-
gets b-catenin such as GSK-3b and Axin while increase the ex-
pressions of Wnt and its receptor/co-receptors (37). Our results
also show that oxidative stress could up-regulate GSK-3b and p-
GSK-3b expressions, while curcumin treatment greatly reduced
these up-regulation. Of note, curcumin treatment could suppress
the expressions of both GSK-3b and p-GSK-3b in normal condi-
tions, which may contribute to the activation of Wnt signaling
pathway. The phosphorylation site of p-GSK3b in our study is
tyrosine 216. Phosphorylation of serine-9 in GSK-3b was reported
to signiﬁcantly decrease GSK3b activity. Conversely, GSK3b ac-
tivity is enhanced by phosphorylation of tyrosine-216 site (38).
From these results, we speculate that curcumin may reverse the
ROS-induced-up-regulation of GSK-3b and p-GSK-3b, leading to
the translocation of more b-catenin into the nucleus to protect
the cells against the impairments induced by oxidative stress.
The mechanistic insights for the relationship between Wnt/b-
catenin signaling and curcumin function may provide further
therapeutic potential besides bone diseases.
5. Conclusion
In a summary, our results have shown that antioxidant curcu-
min, at low concentrations, can protect against the oxidative injury
induced by H2O2 on the survival and osteogenic differentiation of
human adipose-derived mesenchymal stem cells. These effects are
associated with the attenuated oxidative stress by curcumin,
potentially through increasing Wnt/b-catenin signaling. Thus, one
such approach using antioxidant has potential to improve mesen-
chymal stem cell therapy in bone repair.
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